FT 415
497, 2000-04-13
Previous: INTERNATIONAL COSMETICS MARKETING CO, 8-K, 2000-04-13
Next: FT 417, 497, 2000-04-13




                                                        Rule 497(d)

                                     FT 415

                      Bandwidth Select Portfolio, Series 3
                  e-Infrastructure Select Portfolio, Series 2
                Genomics and Proteomics Select Portfolio Series
                   Global Technology Select Portfolio Series
              Software Innovations 2000 Select Portfolio, Series 2
                 World Wide Wireless Select Portfolio, Series 2
                         Bandwidth Portfolio, Series 3
                      e-Infrastructure Portfolio, Series 2
                    Genomics and Proteomics Portfolio Series
                       Global Technology Portfolio Series
                 Software Innovations 2000 Portfolio, Series 3
                     World Wide Wireless Portfolio, Series 2


                Supplement to the Prospectus dated March 3, 2000

Notwithstanding anything to the contrary in the Prospectus, Unit holders who
acquire Units of Genomics and Proteomics Select Portfolio Series, Bandwidth
Portfolio, Series 3, e-Infrastructure Portfolio, Series 2, Genomics and
Proteomics Portfolio Series, Software Innovations 2000 Portfolio, Series 3 or
World Wide Wireless Portfolio, Series 2
which, as a result of a reduction in the aggregate underlying value of the
Securities, are not subject to an initial sales charge will be subject to the
maximum remaining deferred sales charge (initially $.225 per Unit for the
Genomics and Proteomics Select Portfolio Series or $.35 per Unit for the
Genomics and Proteomics Portfolio Series, Bandwidth Portfolio, Series 3,
e-Infrastructure Portfolio, Series 2, the Software Innovations 2000
Portfolio, Series 3 or World Wide Wireless Portfolio, Series 2). In such case
the maximum sales charge may exceed 3.25%
of the Public Offering Price for Genomics and Proteomics Select Portfolio
Series or 4.5% of the Public Offering Price per Unit for Genomics and Proteomics
Portfolio Series, Bandwidth Portfolio, Series 3, e-Infrastructure Portfolio,
Series 2, Software Innovations 2000 Portfolio, Series 3, or World Wide Wireless
Portfolio, Series 2,  but in no
event will the maximum sales charge exceed 3.75% of the Public Offering Price
per Unit for Genomics and Proteomics Select Portfolio Series or 5.50% of the
Public Offering Price per Unit for Genomics and Proteomics Portfolio Series,
Bandwidth Portfolio, Series 3, e-Infrastructure Portfolio, Series 2,
Software Innovations 2000 Portfolio, Series 3 or World Wide Wireless Portfolo,
Series 2.

April 12, 2000




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission